Breaking News
0

Lexicon Pharmaceuticals Inc (LXRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Lexicon's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.830 -0.230    -1.76%
20/07 - Closed. Currency in USD ( Disclaimer )
After Hours
12.830
0.000
0.000%
16:37:20 - Real-time Data
Type: Equity
Market: United States
ISIN: US5288723027 
CUSIP: 528872302
  • Volume: 826,633
  • Bid/Ask: 11.800 / 13.450
  • Day's Range: 12.710 - 13.130
Lexicon 12.830 -0.230 -1.76%

LXRX Overview

 
Information about the Lexicon Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close13.06
Day's Range12.71 - 13.13
Revenue97.25M
Open13.03
52 wk Range7.67 - 17.24
EPS - 1.33
Volume826,633
Market Cap1.37B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)651,313
P/E RatioN/A
Beta0.36
1-Year Change - 23.81%
Shares Outstanding105,812,000
Next Earnings DateJul 31, 2018
What is your sentiment on Lexicon?
or
Market is currently closed. Voting is open during market hours.

Lexicon Pharmaceuticals Inc News


Lexicon Pharmaceuticals Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Sell Neutral Buy Buy
Technical Indicators Sell Strong Sell Strong Sell Strong Buy BUY
Summary Sell Strong Sell Sell Strong Buy Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Three Outside Up 1M 1 Jun 18
Advance Block Bearish 1D 1 Jul 19, 2018
Three Outside Down 30 1 Jul 20, 2018 03:00PM
Bullish Engulfing 1M 2 May 18
Three Outside Up 1D 2 Jul 18, 2018

Lexicon Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 12.830 11.800 13.450 826,633 -1.76% USD 20/07  
  Berlin 11.050 0.000 0.000 0 -2.73% EUR 20/07  
  Munich 10.980 0.000 0.000 0 +0.27% EUR 20/07  
  Stuttgart 11.130 0.000 0.000 0 -0.71% EUR 20/07  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Amazon.com 1,813.70 1,834.84 1,810.06 +0.73 +0.04% 3.89M 20/07  
  Netflix 361.05 370.50 360.14 -3.18 -0.87% 15.11M 20/07  
  Apple 191.44 192.43 190.17 -0.44 -0.23% 20.71M 20/07  
  Microsoft 106.27 108.20 106.08 +1.87 +1.79% 56.04M 20/07  
  Reliance Industries 1,128.65 1,138.50 1,111.90 +23.80 +2.15% 8.02M 20/07  
  Ashok Leyland 107.45 110.00 105.80 +1.75 +1.66% 60.96M 20/07  
  Bajaj Finance 2,721.35 2,745.00 2,486.85 +201.15 +7.98% 7.36M 20/07  
  Facebook 209.94 211.50 208.50 +1.85 +0.89% 16.24M 20/07  
  Tesla 313.58 323.24 311.71 -6.65 -2.08% 5.17M 20/07  
  Bajaj Auto 2,839.60 3,153.80 2,816.45 -275.40 -8.84% 4.98M 20/07  

Lexicon Pharmaceuticals Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

174

Equity Type

ORD

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of breakthrough treatments for human disease. Its drug programs include XERMELO (telotristat ethyl), sotagliflozin, LX2761 and LX9211. It also has a number of additional compounds into various stages of clinical and preclinical development. XERMELO is an orally-delivered small molecule compound approved by the Food and Drug Administration (FDA) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. It is developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for type 1 and type 2 diabetes mellitus. LX2761 is an orally-delivered small molecule compound that it is developing for the treatment of diabetes. LX9211 is an orally-delivered small molecule compound that the Company is developing for the treatment of neuropathic pain.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LXRX Comments

Write your thoughts about Lexicon Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email